Anúncio
Anúncio

ZURA

ZURA logo

Zura Bio Limited Class A Ordinary Shares

5.12
USD
Patrocinado
-0.14
-2.66%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

5.12

0.00
0.00%

Relatórios de Lucros ZURA

Rácio de surpresa positiva

ZURA separação 5 de 10 últimas estimativas.

50%

Próximo Relatório

Data do Próximo Relatório
23 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.20
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-4.76%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
+100.00%

Zura Bio Limited Class A Ordinary Shares earnings per share and revenue

On 13 de nov. de 2025, ZURA reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.18 USD, resulting in a -13.45% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.20 USD, with revenue projected to reach -- USD, implying an diminuir of -4.76% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Zura Bio Limited Class A Ordinary Shares reported EPS of -$0.21, missing estimates by -13.45%, and revenue of $0.00, 0% as expectations.
The stock price moved down -9.72%, changed from $4.63 before the earnings release to $4.18 the day after.
The next earning report is scheduled for 23 de mar. de 2026.
Based on 9 analistas, Zura Bio Limited Class A Ordinary Shares is expected to report EPS of -$0.20 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio